Brucellosis laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:


'''Bacterial Isolation:'''
'''Bacterial Isolation:'''
*The isolation and identification of [[Brucella]] can confirm a [[diagnosis]] of brucellosis. [[Brucella]] is most commonly isolated from [[blood cultures]].
*The isolation and identification of [[Brucella|''Brucella'']] can confirm a [[diagnosis]] of brucellosis. [[Brucella|''Brucella'']] is most commonly isolated from [[blood cultures]].
*It can also, however, be isolated from:
*It can also, however, be isolated from:
**[[Bone marrow]]
**[[Bone marrow]]
Line 34: Line 34:
**If submission of paired sera is not possible, a probable [[diagnosis]] can be made with a single [[serum]] sample.
**If submission of paired sera is not possible, a probable [[diagnosis]] can be made with a single [[serum]] sample.
*''Brucella microagglutination test (BMAT):''  
*''Brucella microagglutination test (BMAT):''  
**A modified version of the serum (tube) agglutination test (SAT), that can detect [[antibodies]] to [[Brucella]] species: [[Brucella abortus|abortus]], [[Brucella melitensis|melitensis]] or suis.  
**A modified version of the serum (tube) agglutination test (SAT), that can detect [[antibodies]] to [[Brucella|''Brucella'']] species: [[Brucella abortus|abortus]], [[Brucella melitensis|melitensis]] or suis.  
**There is no [[Serological testing|serological test]] available to detect [[antibodies]] to [[Brucella canis|B. canis]].
**There is no [[Serological testing|serological test]] available to detect [[antibodies]] to [[Brucella canis|''B. canis'']].
**An [[Agglutination (biology)|agglutination]] titre greater than 1:160 is considered significant in nonendemic areas.
**An [[Agglutination (biology)|''agglutination'']] ''titre greater than 1:160'' is considered significant in nonendemic areas.
**An [[Agglutination (biology)|agglutination]] titre greater than 1:320 is considered significant in [[Endemic (epidemiology)|endemic]] areas.
**An [[Agglutination (biology)|''agglutination'']] ''titre greater than 1:320'' is considered significant in [[Endemic (epidemiology)|endemic]] areas.
**Due to the similarity of the O polysaccharide of [[Brucella]] to that of various other [[Gram-negative bacteria]] (e.g. [[Francisella tularensis]], [[Escherichia coli]], Salmonella urbana, [[Yersinia enterocolitica]], [[Vibrio cholerae]], and [[Stenotrophomonas maltophilia]]) the appearance of cross-reactions of class [[Immunoglobulin M|M immunoglobulins]] may occur.
**Due to the similarity of the O polysaccharide of [[Brucella]] to that of various other [[Gram-negative bacteria]] (e.g. [[Francisella tularensis]], [[Escherichia coli]], Salmonella urbana, [[Yersinia enterocolitica]], [[Vibrio cholerae]], and [[Stenotrophomonas maltophilia]]) the appearance of cross-reactions of class [[Immunoglobulin M|M immunoglobulins]] may occur.
**[[False-negative test result|False-negative]] SAT may be caused by the presence of blocking [[antibodies]] (the [[prozone]] phenomenon) in the α2-globulin ([[IgA]]) and in the α-globulin ([[IgG]]) fractions.
**[[False-negative test result|False-negative]] SAT may be caused by the presence of blocking [[antibodies]] (the [[prozone]] phenomenon) in the α2-globulin ([[IgA]]) and in the α-globulin ([[IgG]]) fractions.
Line 43: Line 43:
*''Rose Bengal'':
*''Rose Bengal'':
**Rose bengal has a [[positive predictive value]] is approximately 99% for [[patients]] with [[Acute (medical)|acute]] and [[Chronic (medical)|chronic]] brucellosis.
**Rose bengal has a [[positive predictive value]] is approximately 99% for [[patients]] with [[Acute (medical)|acute]] and [[Chronic (medical)|chronic]] brucellosis.
**It measures [[IgM]] and [[IgG]] [[antibodies]].
**Rose bengal measures [[IgM]] and [[IgG]] [[antibodies]].
*''2-mercaptoethanol (2-ME)'':
*''2-mercaptoethanol (2-ME)'':
**It measures [[IgG]] [[antibodies]].
**2-ME measures [[IgG]] [[antibodies]].
*''Antihuman globulin ([[Coombs' Test|Coombs]]):''
*''Antihuman globulin ([[Coombs' Test|Coombs]]):''
**Used in [[Chronic (medical)|chronic]] brucellosis patients with negative seroagglutination because they have [[IgG]] non-agglutinating [[Antibodies|antibodies.]]
**Used in [[Chronic (medical)|chronic]] brucellosis patients with negative seroagglutination because they have [[IgG]] non-agglutinating [[Antibodies|antibodies.]]
*''[[Enzyme linked immunosorbent assay (ELISA)|Indirect enzyme linked immunosorbent assay (ELISA)]]:''
*''[[Enzyme linked immunosorbent assay (ELISA)|Indirect enzyme linked immunosorbent assay (ELISA)]]:''
**[[ELISA test|ELISA]] typically uses [[cytoplasmic]] [[proteins]] as [[antigens]].  
**[[ELISA test|ELISA]] typically uses [[cytoplasmic]] [[proteins]] as [[antigens]].  
**It measures [[IgM]], [[IgG]], and [[IgA]] with better [[Sensitivity (tests)|sensitivity]] and [[Specificity (tests)|specificity]] than the SAT in most recent comparative studies.
**[[ELISA test|ELISA]] measures [[IgM]], [[IgG]], and [[IgA]] with better [[Sensitivity (tests)|sensitivity]] and [[Specificity (tests)|specificity]] than the SAT in most recent comparative studies.
*''Dipstick assays:''  
*''Dipstick assays:''  
**New and promising, based on the binding of [[Brucella]] [[IgM]] [[antibodies]], and found to be simple, accurate, and rapid.
**New and promising, based on the binding of [[Brucella]] [[IgM]] [[antibodies]], and found to be simple, accurate, and rapid.

Revision as of 19:46, 5 February 2016

Brucellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brucellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Principles of diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brucellosis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brucellosis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brucellosis laboratory findings

CDC on Brucellosis laboratory findings

Brucellosis laboratory findings in the news

Blogs on Brucellosis laboratory findings

Directions to Hospitals Treating Brucellosis

Risk calculators and risk factors for Brucellosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Danitza Lukac

Overview

A positive culture or presence of Brucella antibody in serological tests are diagnostic of brucellosis.[1]

Laboratory Findings

Bacterial Isolation:

Serological tests:

Gallery

References

  1. Brucellosis 2010 Case Definition. CDC. http://wwwn.cdc.gov/nndss/conditions/brucellosis/case-definition/2010/. Accessed on February 2, 2016
  2. 2.0 2.1 2.2 Pappas G, Akritidis N, Bosilkovski M, Tsianos E (2005). "Brucellosis". N Engl J Med. 352 (22): 2325–36. doi:10.1056/NEJMra050570. PMID 15930423.
  3. Brucellosis. CDC. http://www.cdc.gov/brucellosis/transmission/index.html. Accessed on February 1, 2016
  4. Brucellosis. CDC. http://www.cdc.gov/brucellosis/clinicians/bacterial-isolation.html. Accessed on February 4, 2016
  5. 5.0 5.1 Brucellosis. CDC. http://www.cdc.gov/brucellosis/transmission/index.html. Accessed on February 1, 2016
  6. Brucelosis. Wikipedia. https://es.wikipedia.org/wiki/Brucelosis. Accessed on February 2, 2016
  7. 7.00 7.01 7.02 7.03 7.04 7.05 7.06 7.07 7.08 7.09 7.10 7.11 "Public Health Image Library (PHIL)".

Template:WH Template:WS